Is it reasonable to wean a 6-year-old patient with suspected vasovagal syncope, currently on Keppra (levetiracetam), off the medication and request a follow-up EEG and tilt test?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 5, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Weaning Keppra in Suspected Vasovagal Syncope

Yes, it is reasonable to wean Keppra (levetiracetam) in this 6-year-old with suspected vasovagal syncope, as antiepileptic medications are not indicated for syncope and may represent a misdiagnosis. 1

Rationale for Discontinuing Keppra

  • Routine EEG is not recommended for syncope evaluation in the absence of specific neurological features suggestive of seizures 1
  • Vasovagal syncope can mimic epileptic seizures with brief convulsive movements during loss of consciousness, but these do not require antiepileptic treatment 1, 2
  • In pediatric patients with syncope and convulsions on tilt-table testing, 64% exhibited cardiac asystole with pauses >3 seconds, confirming a cardiac rather than epileptic etiology 1
  • Many patients are inappropriately treated with antiepileptic drugs when they actually have vasovagal syncope—one study found 27 of 45 patients previously treated with antiepileptic medications did not have epilepsy 3

Role of Follow-Up EEG

  • EEG should only be pursued if there are specific neurological features suggesting true seizures (focal neurological findings, prolonged postictal confusion, seizures occurring from sleep, tongue biting, incontinence) 1
  • If the clinical history clearly indicates syncope with brief seizure-like activity, EEG is unnecessary and may lead to misdiagnosis 1
  • A combined cardiology and neurology evaluation may be warranted only in patients with syncope and seizure-like activity where the diagnosis remains unclear 1

Role of Tilt-Table Testing

  • Tilt-table testing can be useful for pediatric patients with suspected vasovagal syncope when the diagnosis is unclear after initial evaluation 1
  • The sensitivity of tilt-table testing in children ranges from 20% to 90%, with specificity from 83% to 100% 1
  • However, tilt-table testing is not necessary when the initial assessment indicates an uncomplicated faint with typical features (the "3 Ps": posture-related, provoking factors like pain, prodromal symptoms like sweating) 1
  • Tilt-table testing is particularly helpful to distinguish convulsive syncope from epilepsy in selected patients 1

Appropriate Management Strategy

Instead of reflexively ordering both tests, follow this algorithm:

  1. Review the clinical history carefully for features of uncomplicated vasovagal syncope: episodes during prolonged standing, clear triggers (pain, medical procedures, emotional stress), prodromal symptoms (sweating, feeling warm), and age-appropriate recurrence pattern 1, 4

  2. Ensure 12-lead ECG has been performed to exclude cardiac arrhythmias or structural heart disease 1, 4

  3. If history is typical for vasovagal syncope with normal ECG:

    • Wean Keppra (no indication for antiepileptic therapy) 1
    • Skip EEG (not indicated) 1
    • Consider skipping tilt-table test if diagnosis is clear 1
    • Focus on education, reassurance, and lifestyle measures 1, 4
  4. If diagnosis remains unclear or seizure-like features are prominent:

    • Proceed with tilt-table testing to confirm vasovagal syncope 1
    • Consider EEG only if true epileptic features persist after tilt-table testing 1

First-Line Treatment for Pediatric Vasovagal Syncope

Once vasovagal syncope is confirmed, appropriate management includes:

  • Education on symptom awareness and reassurance about the benign nature of the condition 1, 4
  • Avoidance of precipitating factors (dehydration, prolonged standing, hot crowded environments) 1
  • Increased salt and fluid intake may be reasonable (Class IIb recommendation in pediatrics) 1
  • Midodrine is reasonable if lifestyle measures fail (Class IIa recommendation, associated with 78% reduction in recurrence in pediatric RCT) 1

Common Pitfall to Avoid

The most critical error is continuing antiepileptic therapy for what is actually vasovagal syncope. 2, 3 This leads to unnecessary medication exposure, side effects, and failure to address the true diagnosis with appropriate education and lifestyle modifications that form the cornerstone of vasovagal syncope management. 1, 4

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Vasovagal syncope treated as epilepsy for 16 years.

Iranian journal of medical sciences, 2011

Guideline

Management of Vasodepressive Neurocardiogenic Syncope

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.